Overview

LEO19123 Cream in the Treatment of Atopic Dermatitis

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of two different dose combinations of LEO19123 (calcipotriol and LEO80122) with LEO19123 cream vehicle for 3 weeks in the treatment of patients with atopic dermatitis
Phase:
Phase 2
Details
Lead Sponsor:
LEO Pharma
Treatments:
Calcipotriene